KiwiBiotic对功能性便秘和相关症状的影响:一个前性,单中心,随机,比较,交叉研究
Ashwin D Porwal1, Paresh M Gandhi2, Deepak K Kulkarni2
1Department of Proctology, Healing Hands Clinic, Mahārāshtra, Pune 411001, India. drashwinporwal@healinghandsclinic.co.in.
World journal of gastrointestinal pharmacology and therapeutics
|September 16, 2024
概括
KiwiBiotic有效地管理功能性便秘 (FC) 症状,如腹部疼痛和胀气,表现优于皮. 超过90%的患者经历了缓解,显示了其作为一种有价值的替代疗法的潜力.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 临床营养学 临床营养学
背景情况:
- 功能性便秘 (FC) 显著影响患者的生活质量.
- 传统的FC治疗方法往往无法提供足够的缓解.
- 对FC的新型治疗剂的研究至关重要.
研究的目的:
- 评估KiwiBiotic在治疗功能性便秘方面的疗效.
- 为了比较KiwiBiotic与psyllium用于缓解FC症状.
主要方法:
- 前性,干预性,单中心,交叉研究设计.
- 随机分配到KiwiBiotic或皮.
- 在治疗阶段之间有14天的洗期.
主要成果:
- 与皮相比,KiwiBiotic在减少腹部疼痛和胀气方面表现出更高的疗效.
- 超过90%的参与者报告说,使用KiwiBiotic可以缓解便秘症状.
- 基维生物显示出明显更好的结果比皮.
结论:
- KiwiBiotic是一种安全有效的功能性便秘治疗方法.
- 基维生物为FC症状提供了一个有前途的替代疗法.
- 这项研究支持KiwiBiotic在管理与FC相关的腹痛和胀气方面的作用.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
145
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
145
Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
147
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
147
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
324
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
324
Irritable Bowel Syndrome III: Medical and Nursing Management
180
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
180
Irritable Bowel Syndrome I: Introduction
257
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
257


